Neurogene Inc (NGNE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Operating Expenses | 6,310 | 5,632 | 2,615 | 3,310 | 3,417 |
| Operating Income | -6,310 | -5,632 | -2,615 | -3,310 | -3,417 |
| Interest Expense | 0 | 0 | 0 | 40 | 0 |
| Other Income | 26 | 208 | -1,613 | -190 | 45 |
| Pre-tax Income | -6,284 | -5,424 | -4,228 | -3,540 | -3,373 |
| Income Tax | N/A | N/A | N/A | 10 | -5 |
| Net Income Continuous | -6,284 | -5,424 | -4,228 | -3,550 | -3,368 |
| Net Income | $-6,284 | $-5,424 | $-4,228 | $-3,540 | $-3,368 |
| EPS Basic Total Ops | -11.80 | -10.20 | -25.60 | -350.20 | -312.80 |
| EPS Basic Continuous Ops | -11.75 | -10.16 | -26.86 | -235.03 | -223.01 |
| EPS Diluted Total Ops | -11.80 | -10.20 | -25.60 | -350.20 | -312.80 |
| EPS Diluted Continuous Ops | -11.75 | -10.16 | -26.86 | -235.03 | -223.01 |
| EBITDA(a) | $-6,310 | $-5,632 | $-731 | $-3,181 | $-3,282 |